Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.
about
Adenosine signaling and function in glial cellsAdenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemiaSex differences in caffeine neurotoxicity following chronic ethanol exposure and withdrawalActivation of Trk neurotrophin receptors in the absence of neurotrophinsUsing caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.Regulation of foam cells by adenosine.Adenosine in the treatment of stroke: yes, maybe, or absolutely not?Adenosine and neurotrauma: therapeutic perspectives.Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction.Decreased extracellular adenosine levels lead to loss of hypoxia-induced neuroprotection after repeated episodes of exposure to hypoxia.Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slicesAdenosine kinase determines the degree of brain injury after ischemic stroke in mice.Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated ratsAdenosine, neurodegeneration and neuroprotection.The protective effect of adenosine A2A receptor antagonism in cerebral ischemia.The role of ATP and adenosine in the brain under normoxic and ischemic conditionsAdenosine receptor ligands: differences with acute versus chronic treatment.Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist.The A2A adenosine receptor is a dual coding gene: a novel mechanism of gene usage and signal transduction.Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury.How does adenosine control neuronal dysfunction and neurodegeneration?Treatment of acute cerebral ischemia using animal models: a meta-analysis.Pathological overproduction: the bad side of adenosine.Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockadeNuclear Factor κB and Adenosine Receptors: Biochemical and Behavioral Profiling.Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists.Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant.The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.Cortical spreading depression-induced preconditioning in mouse neocortex is lamina specific.Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia.Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain.Adenosine receptor expression in an experimental animal model of myocardial infarction with preserved left ventricular ejection fraction.CNS-specific prostacyclin ligands as neuronal survival-promoting factors in the brain.Restoring adenine nucleotides in a brain slice model of cerebral reperfusion.Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.Biochemical and Pharmacological Role of A1 Adenosine Receptors and Their Modulation as Novel Therapeutic Strategy.Continuous adenosine A2A receptor antagonism after focal cerebral ischemia in spontaneously hypertensive rats.Adenosine A2AReceptors and NeuroprotectionNeuroprotection by A2A receptor antagonists
P2860
Q24634273-82D6533C-5A40-4405-A92A-235F4686990FQ26851322-8DE8C40F-5ED1-4021-B899-66CEB0AE63E5Q33741040-5B9DECDD-ECCA-4194-B57D-91FEE0D9FF36Q33937877-9D67744C-B314-442C-A843-F8CEED902F66Q33971113-BC53CCB5-4FB4-4E60-9058-B74D6C2BFE20Q34031160-D84DAE12-E50A-45EA-BBE8-706388A42810Q34204326-394FAF51-E7D0-4894-ACB9-D89D50F37BC6Q34230282-F51E3A00-4792-4A0C-BA71-8F2B6CA46746Q34292324-9B32C9D0-FA16-40FD-8744-410A4167BF89Q34599971-CAB130C1-35D0-4B1C-AFE6-664685F47632Q35041668-B2E2296F-B16A-4730-AA36-6B13F4D022F0Q35108543-30E2BC9D-88C1-4A95-8CBA-635533CD1B50Q35635814-A5C1B1BC-55F9-42CA-B96B-59F3521A6EDDQ36097330-12500D8C-4F66-4471-B5DB-D71E99AB5DEDQ36097335-64DCED0D-78C2-453B-8716-3FD8FEB0D672Q36131077-1E16CF69-B603-4F56-BBEB-7E19CE1F2917Q36200374-867E3E17-7CF8-43E9-A764-5E30897660C5Q36225561-059CA4A8-507B-491B-A261-2C0F6FAE7E50Q37488413-D6D53FC9-B70A-4A24-B40A-536CCA2D90AAQ37863150-837EF570-39E8-41F0-844C-F40427669989Q38882782-90FFEB95-0D0F-4A23-91E6-17F50DAF06CCQ39042361-F58FD980-A56E-4DCE-932C-48EB9348952BQ39157893-E5E65451-285B-444D-80E6-9AD32C82B317Q40722338-C0BEAE1B-8C47-4F56-A3AC-5F78C95FF295Q41767515-6056A23B-B3E4-43FC-9C0C-393B110328CFQ42065141-266FF636-1BB1-4BAE-A360-62446BF82E49Q42594826-760282A8-36C3-4531-9009-7CEB0D4ADAD7Q43078271-1CE3A2B5-8B26-4873-AF13-2F32BB5587F3Q44662833-DFF9E2E9-6EC0-4359-9970-D6D06D45245EQ46643979-0E221353-CB31-4241-A8DE-BD5B28929F64Q46937494-6EE98C3E-0065-439D-8AE8-0022841268C8Q48030648-06586AF9-5D38-4C41-9CA1-F21A50ECEA26Q48098697-FCCD5BF7-6FF1-45A4-A550-096C5062A2DCQ48450098-600C092B-90D1-49D1-9029-61228FDB8275Q48491942-3A946E78-51B8-4224-86A1-D5C5A3ECED2FQ48732639-0C81040D-5ECC-4A1B-AD5B-2BC6820905B5Q48906414-7B0E4CF9-6F53-45BF-BA7B-34D57A995B65Q56700736-7B274F82-47E5-4F89-8CCF-26F4EBB29A36Q58852531-F4AE85C2-779B-4255-9413-4EDB16C36C92
P2860
Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Cerebral ischemia in gerbils: ...... ceptor agonist and antagonist.
@en
type
label
Cerebral ischemia in gerbils: ...... ceptor agonist and antagonist.
@en
prefLabel
Cerebral ischemia in gerbils: ...... ceptor agonist and antagonist.
@en
P2093
P2860
P1476
Cerebral ischemia in gerbils: ...... ceptor agonist and antagonist.
@en
P2093
D K Von Lubitz
K A Jacobson
P2860
P304
P356
10.1016/0014-2999(95)00498-X
P407
P577
1995-12-01T00:00:00Z